Global Recombinant DNA Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Recombinant DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
The Global Recombinant DNA Vaccine Market Size was estimated at USD 214.45 million in 2023 and is projected to reach USD 503.86 million by 2029, exhibiting a CAGR of 15.30% during the forecast period.
This report provides a deep insight into the global Recombinant DNA Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant DNA Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant DNA Vaccine market in any manner.
Global Recombinant DNA Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market Segmentation (by Type)
Recombinant Protein Vaccine
Gene-Based Vaccine
Market Segmentation (by Application)
Human
Animal
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant DNA Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Recombinant DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
The Global Recombinant DNA Vaccine Market Size was estimated at USD 214.45 million in 2023 and is projected to reach USD 503.86 million by 2029, exhibiting a CAGR of 15.30% during the forecast period.
This report provides a deep insight into the global Recombinant DNA Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant DNA Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant DNA Vaccine market in any manner.
Global Recombinant DNA Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market Segmentation (by Type)
Recombinant Protein Vaccine
Gene-Based Vaccine
Market Segmentation (by Application)
Human
Animal
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Recombinant DNA Vaccine Market
- Overview of the regional outlook of the Recombinant DNA Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant DNA Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Recombinant DNA Vaccine
1.2 Key Market Segments
1.2.1 Recombinant DNA Vaccine Segment by Type
1.2.2 Recombinant DNA Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT DNA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant DNA Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant DNA Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT DNA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant DNA Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Recombinant DNA Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant DNA Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant DNA Vaccine Sales Sites, Area Served, Product Type
3.6 Recombinant DNA Vaccine Market Competitive Situation and Trends
3.6.1 Recombinant DNA Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant DNA Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT DNA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Recombinant DNA Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT DNA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT DNA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant DNA Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Recombinant DNA Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant DNA Vaccine Price by Type (2019-2024)
7 RECOMBINANT DNA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant DNA Vaccine Market Sales by Application (2019-2024)
7.3 Global Recombinant DNA Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant DNA Vaccine Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT DNA VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Recombinant DNA Vaccine Sales by Region
8.1.1 Global Recombinant DNA Vaccine Sales by Region
8.1.2 Global Recombinant DNA Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant DNA Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant DNA Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant DNA Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant DNA Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant DNA Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Recombinant DNA Vaccine Basic Information
9.1.2 Merck Recombinant DNA Vaccine Product Overview
9.1.3 Merck Recombinant DNA Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Recombinant DNA Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Recombinant DNA Vaccine Basic Information
9.2.2 GSK Recombinant DNA Vaccine Product Overview
9.2.3 GSK Recombinant DNA Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Recombinant DNA Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Recombinant DNA Vaccine Basic Information
9.3.2 Sanofi Recombinant DNA Vaccine Product Overview
9.3.3 Sanofi Recombinant DNA Vaccine Product Market Performance
9.3.4 Sanofi Recombinant DNA Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Zoties
9.4.1 Zoties Recombinant DNA Vaccine Basic Information
9.4.2 Zoties Recombinant DNA Vaccine Product Overview
9.4.3 Zoties Recombinant DNA Vaccine Product Market Performance
9.4.4 Zoties Business Overview
9.4.5 Zoties Recent Developments
9.5 Elanco
9.5.1 Elanco Recombinant DNA Vaccine Basic Information
9.5.2 Elanco Recombinant DNA Vaccine Product Overview
9.5.3 Elanco Recombinant DNA Vaccine Product Market Performance
9.5.4 Elanco Business Overview
9.5.5 Elanco Recent Developments
9.6 Boehringer-Ingelheim
9.6.1 Boehringer-Ingelheim Recombinant DNA Vaccine Basic Information
9.6.2 Boehringer-Ingelheim Recombinant DNA Vaccine Product Overview
9.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Product Market Performance
9.6.4 Boehringer-Ingelheim Business Overview
9.6.5 Boehringer-Ingelheim Recent Developments
9.7 Indian Immunologicals
9.7.1 Indian Immunologicals Recombinant DNA Vaccine Basic Information
9.7.2 Indian Immunologicals Recombinant DNA Vaccine Product Overview
9.7.3 Indian Immunologicals Recombinant DNA Vaccine Product Market Performance
9.7.4 Indian Immunologicals Business Overview
9.7.5 Indian Immunologicals Recent Developments
9.8 Plumbline Life Sciences
9.8.1 Plumbline Life Sciences Recombinant DNA Vaccine Basic Information
9.8.2 Plumbline Life Sciences Recombinant DNA Vaccine Product Overview
9.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Product Market Performance
9.8.4 Plumbline Life Sciences Business Overview
9.8.5 Plumbline Life Sciences Recent Developments
10 RECOMBINANT DNA VACCINE MARKET FORECAST BY REGION
10.1 Global Recombinant DNA Vaccine Market Size Forecast
10.2 Global Recombinant DNA Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant DNA Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant DNA Vaccine Market Size Forecast by Region
10.2.4 South America Recombinant DNA Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant DNA Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant DNA Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant DNA Vaccine by Type (2025-2030)
11.1.2 Global Recombinant DNA Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant DNA Vaccine by Type (2025-2030)
11.2 Global Recombinant DNA Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant DNA Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Recombinant DNA Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Recombinant DNA Vaccine
1.2 Key Market Segments
1.2.1 Recombinant DNA Vaccine Segment by Type
1.2.2 Recombinant DNA Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT DNA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant DNA Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant DNA Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT DNA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant DNA Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Recombinant DNA Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant DNA Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant DNA Vaccine Sales Sites, Area Served, Product Type
3.6 Recombinant DNA Vaccine Market Competitive Situation and Trends
3.6.1 Recombinant DNA Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant DNA Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT DNA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Recombinant DNA Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT DNA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT DNA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant DNA Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Recombinant DNA Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant DNA Vaccine Price by Type (2019-2024)
7 RECOMBINANT DNA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant DNA Vaccine Market Sales by Application (2019-2024)
7.3 Global Recombinant DNA Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant DNA Vaccine Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT DNA VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Recombinant DNA Vaccine Sales by Region
8.1.1 Global Recombinant DNA Vaccine Sales by Region
8.1.2 Global Recombinant DNA Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant DNA Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant DNA Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant DNA Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant DNA Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant DNA Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Recombinant DNA Vaccine Basic Information
9.1.2 Merck Recombinant DNA Vaccine Product Overview
9.1.3 Merck Recombinant DNA Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Recombinant DNA Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Recombinant DNA Vaccine Basic Information
9.2.2 GSK Recombinant DNA Vaccine Product Overview
9.2.3 GSK Recombinant DNA Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Recombinant DNA Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Recombinant DNA Vaccine Basic Information
9.3.2 Sanofi Recombinant DNA Vaccine Product Overview
9.3.3 Sanofi Recombinant DNA Vaccine Product Market Performance
9.3.4 Sanofi Recombinant DNA Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Zoties
9.4.1 Zoties Recombinant DNA Vaccine Basic Information
9.4.2 Zoties Recombinant DNA Vaccine Product Overview
9.4.3 Zoties Recombinant DNA Vaccine Product Market Performance
9.4.4 Zoties Business Overview
9.4.5 Zoties Recent Developments
9.5 Elanco
9.5.1 Elanco Recombinant DNA Vaccine Basic Information
9.5.2 Elanco Recombinant DNA Vaccine Product Overview
9.5.3 Elanco Recombinant DNA Vaccine Product Market Performance
9.5.4 Elanco Business Overview
9.5.5 Elanco Recent Developments
9.6 Boehringer-Ingelheim
9.6.1 Boehringer-Ingelheim Recombinant DNA Vaccine Basic Information
9.6.2 Boehringer-Ingelheim Recombinant DNA Vaccine Product Overview
9.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Product Market Performance
9.6.4 Boehringer-Ingelheim Business Overview
9.6.5 Boehringer-Ingelheim Recent Developments
9.7 Indian Immunologicals
9.7.1 Indian Immunologicals Recombinant DNA Vaccine Basic Information
9.7.2 Indian Immunologicals Recombinant DNA Vaccine Product Overview
9.7.3 Indian Immunologicals Recombinant DNA Vaccine Product Market Performance
9.7.4 Indian Immunologicals Business Overview
9.7.5 Indian Immunologicals Recent Developments
9.8 Plumbline Life Sciences
9.8.1 Plumbline Life Sciences Recombinant DNA Vaccine Basic Information
9.8.2 Plumbline Life Sciences Recombinant DNA Vaccine Product Overview
9.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Product Market Performance
9.8.4 Plumbline Life Sciences Business Overview
9.8.5 Plumbline Life Sciences Recent Developments
10 RECOMBINANT DNA VACCINE MARKET FORECAST BY REGION
10.1 Global Recombinant DNA Vaccine Market Size Forecast
10.2 Global Recombinant DNA Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant DNA Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant DNA Vaccine Market Size Forecast by Region
10.2.4 South America Recombinant DNA Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant DNA Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant DNA Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant DNA Vaccine by Type (2025-2030)
11.1.2 Global Recombinant DNA Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant DNA Vaccine by Type (2025-2030)
11.2 Global Recombinant DNA Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant DNA Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Recombinant DNA Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant DNA Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Recombinant DNA Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant DNA Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant DNA Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Vaccine as of 2022)
Table 10. Global Market Recombinant DNA Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant DNA Vaccine Sales Sites and Area Served
Table 12. Manufacturers Recombinant DNA Vaccine Product Type
Table 13. Global Recombinant DNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant DNA Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant DNA Vaccine Market Challenges
Table 22. Global Recombinant DNA Vaccine Sales by Type (Kilotons)
Table 23. Global Recombinant DNA Vaccine Market Size by Type (M USD)
Table 24. Global Recombinant DNA Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Recombinant DNA Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant DNA Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant DNA Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Recombinant DNA Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Recombinant DNA Vaccine Sales (Kilotons) by Application
Table 30. Global Recombinant DNA Vaccine Market Size by Application
Table 31. Global Recombinant DNA Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Recombinant DNA Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant DNA Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant DNA Vaccine Market Share by Application (2019-2024)
Table 35. Global Recombinant DNA Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant DNA Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Recombinant DNA Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant DNA Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Recombinant DNA Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Recombinant DNA Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Recombinant DNA Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Recombinant DNA Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Recombinant DNA Vaccine Basic Information
Table 44. Merck Recombinant DNA Vaccine Product Overview
Table 45. Merck Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Recombinant DNA Vaccine SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Recombinant DNA Vaccine Basic Information
Table 50. GSK Recombinant DNA Vaccine Product Overview
Table 51. GSK Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Recombinant DNA Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Recombinant DNA Vaccine Basic Information
Table 56. Sanofi Recombinant DNA Vaccine Product Overview
Table 57. Sanofi Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Recombinant DNA Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Zoties Recombinant DNA Vaccine Basic Information
Table 62. Zoties Recombinant DNA Vaccine Product Overview
Table 63. Zoties Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Zoties Business Overview
Table 65. Zoties Recent Developments
Table 66. Elanco Recombinant DNA Vaccine Basic Information
Table 67. Elanco Recombinant DNA Vaccine Product Overview
Table 68. Elanco Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Elanco Business Overview
Table 70. Elanco Recent Developments
Table 71. Boehringer-Ingelheim Recombinant DNA Vaccine Basic Information
Table 72. Boehringer-Ingelheim Recombinant DNA Vaccine Product Overview
Table 73. Boehringer-Ingelheim Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Boehringer-Ingelheim Business Overview
Table 75. Boehringer-Ingelheim Recent Developments
Table 76. Indian Immunologicals Recombinant DNA Vaccine Basic Information
Table 77. Indian Immunologicals Recombinant DNA Vaccine Product Overview
Table 78. Indian Immunologicals Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Indian Immunologicals Business Overview
Table 80. Indian Immunologicals Recent Developments
Table 81. Plumbline Life Sciences Recombinant DNA Vaccine Basic Information
Table 82. Plumbline Life Sciences Recombinant DNA Vaccine Product Overview
Table 83. Plumbline Life Sciences Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Plumbline Life Sciences Business Overview
Table 85. Plumbline Life Sciences Recent Developments
Table 86. Global Recombinant DNA Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Recombinant DNA Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Recombinant DNA Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Recombinant DNA Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Recombinant DNA Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Recombinant DNA Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Recombinant DNA Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Recombinant DNA Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Recombinant DNA Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Recombinant DNA Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Recombinant DNA Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Recombinant DNA Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Recombinant DNA Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant DNA Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Recombinant DNA Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant DNA Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant DNA Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Vaccine as of 2022)
Table 10. Global Market Recombinant DNA Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant DNA Vaccine Sales Sites and Area Served
Table 12. Manufacturers Recombinant DNA Vaccine Product Type
Table 13. Global Recombinant DNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant DNA Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant DNA Vaccine Market Challenges
Table 22. Global Recombinant DNA Vaccine Sales by Type (Kilotons)
Table 23. Global Recombinant DNA Vaccine Market Size by Type (M USD)
Table 24. Global Recombinant DNA Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Recombinant DNA Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant DNA Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant DNA Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Recombinant DNA Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Recombinant DNA Vaccine Sales (Kilotons) by Application
Table 30. Global Recombinant DNA Vaccine Market Size by Application
Table 31. Global Recombinant DNA Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Recombinant DNA Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant DNA Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant DNA Vaccine Market Share by Application (2019-2024)
Table 35. Global Recombinant DNA Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant DNA Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Recombinant DNA Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant DNA Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Recombinant DNA Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Recombinant DNA Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Recombinant DNA Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Recombinant DNA Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Recombinant DNA Vaccine Basic Information
Table 44. Merck Recombinant DNA Vaccine Product Overview
Table 45. Merck Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Recombinant DNA Vaccine SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Recombinant DNA Vaccine Basic Information
Table 50. GSK Recombinant DNA Vaccine Product Overview
Table 51. GSK Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Recombinant DNA Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Recombinant DNA Vaccine Basic Information
Table 56. Sanofi Recombinant DNA Vaccine Product Overview
Table 57. Sanofi Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Recombinant DNA Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Zoties Recombinant DNA Vaccine Basic Information
Table 62. Zoties Recombinant DNA Vaccine Product Overview
Table 63. Zoties Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Zoties Business Overview
Table 65. Zoties Recent Developments
Table 66. Elanco Recombinant DNA Vaccine Basic Information
Table 67. Elanco Recombinant DNA Vaccine Product Overview
Table 68. Elanco Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Elanco Business Overview
Table 70. Elanco Recent Developments
Table 71. Boehringer-Ingelheim Recombinant DNA Vaccine Basic Information
Table 72. Boehringer-Ingelheim Recombinant DNA Vaccine Product Overview
Table 73. Boehringer-Ingelheim Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Boehringer-Ingelheim Business Overview
Table 75. Boehringer-Ingelheim Recent Developments
Table 76. Indian Immunologicals Recombinant DNA Vaccine Basic Information
Table 77. Indian Immunologicals Recombinant DNA Vaccine Product Overview
Table 78. Indian Immunologicals Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Indian Immunologicals Business Overview
Table 80. Indian Immunologicals Recent Developments
Table 81. Plumbline Life Sciences Recombinant DNA Vaccine Basic Information
Table 82. Plumbline Life Sciences Recombinant DNA Vaccine Product Overview
Table 83. Plumbline Life Sciences Recombinant DNA Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Plumbline Life Sciences Business Overview
Table 85. Plumbline Life Sciences Recent Developments
Table 86. Global Recombinant DNA Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Recombinant DNA Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Recombinant DNA Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Recombinant DNA Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Recombinant DNA Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Recombinant DNA Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Recombinant DNA Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Recombinant DNA Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Recombinant DNA Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Recombinant DNA Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Recombinant DNA Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Recombinant DNA Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Recombinant DNA Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Recombinant DNA Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Recombinant DNA Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant DNA Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Recombinant DNA Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant DNA Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant DNA Vaccine Market Size by Country (M USD)
Figure 11. Recombinant DNA Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant DNA Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant DNA Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant DNA Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant DNA Vaccine Market Share by Type
Figure 18. Sales Market Share of Recombinant DNA Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant DNA Vaccine by Type in 2023
Figure 20. Market Size Share of Recombinant DNA Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant DNA Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant DNA Vaccine Market Share by Application
Figure 24. Global Recombinant DNA Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant DNA Vaccine Sales Market Share by Application in 2023
Figure 26. Global Recombinant DNA Vaccine Market Share by Application (2019-2024)
Figure 27. Global Recombinant DNA Vaccine Market Share by Application in 2023
Figure 28. Global Recombinant DNA Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant DNA Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Recombinant DNA Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Recombinant DNA Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant DNA Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Recombinant DNA Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Recombinant DNA Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Recombinant DNA Vaccine Sales Market Share by Region in 2023
Figure 44. China Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Recombinant DNA Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Recombinant DNA Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Recombinant DNA Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Recombinant DNA Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Recombinant DNA Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Recombinant DNA Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant DNA Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant DNA Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant DNA Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant DNA Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Recombinant DNA Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant DNA Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Recombinant DNA Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant DNA Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant DNA Vaccine Market Size by Country (M USD)
Figure 11. Recombinant DNA Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant DNA Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant DNA Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant DNA Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant DNA Vaccine Market Share by Type
Figure 18. Sales Market Share of Recombinant DNA Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant DNA Vaccine by Type in 2023
Figure 20. Market Size Share of Recombinant DNA Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant DNA Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant DNA Vaccine Market Share by Application
Figure 24. Global Recombinant DNA Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant DNA Vaccine Sales Market Share by Application in 2023
Figure 26. Global Recombinant DNA Vaccine Market Share by Application (2019-2024)
Figure 27. Global Recombinant DNA Vaccine Market Share by Application in 2023
Figure 28. Global Recombinant DNA Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant DNA Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Recombinant DNA Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Recombinant DNA Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant DNA Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Recombinant DNA Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Recombinant DNA Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Recombinant DNA Vaccine Sales Market Share by Region in 2023
Figure 44. China Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Recombinant DNA Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Recombinant DNA Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Recombinant DNA Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Recombinant DNA Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Recombinant DNA Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Recombinant DNA Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Recombinant DNA Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant DNA Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant DNA Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant DNA Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant DNA Vaccine Market Share Forecast by Application (2025-2030)
